Healing agent for preventing swelling and resisting infection after surgery

A surgical operation and healing agent technology, which is applied in the direction of anti-infective drugs, anti-inflammatory agents, drug combinations, etc., can solve the problems of large side effects, poor patient acceptance, poor healing agent effect, etc., achieve high drug concentration, reduce pain, The effect of preventing infection

Inactive Publication Date: 2017-12-22
滕敏子
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The object of the present invention is to provide a healing agent for anti-swelling and anti-infection after surgery, to solve the defects of poor healing effect, large side effects and poor patient acceptance in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] In the present embodiment, the healing agent for anti-swelling and anti-infection after surgery of the present invention includes 0.05% cetylpyridinium chloride, 1% serrapeptase, 50% epidermal growth factor, 0.5% xanthan gum, 5% Collagen, 0.2% phenoxyethanol, 0.6% ethylhexylglycerin, 16.1% plasmin.

Embodiment 2

[0025] In the present embodiment, a healing agent for anti-swelling and anti-infection after surgery of the present invention includes 0.1% cetylpyridinium chloride, 2% serrapeptase, 70% epidermal growth factor, 0.8% Xanthan gum, 10% collagen, 0.2% phenoxyethanol, 0.8% ethylhexylglycerin, 42.65% plasmin.

Embodiment 3

[0027] In the present embodiment, a healing agent for anti-swelling and anti-infection after surgery of the present invention includes 0.08% cetylpyridinium chloride, 1.5% serrapeptase, 60% epidermal growth factor, and 0.65% Xanthan gum, 8% collagen, 0.2% phenoxyethanol, 0.7% ethylhexylglycerin, 29.38% plasmin.

[0028] The medicines in the above-mentioned Examples 1 to 3 are mixed and formulated to be viscous, and mixed for use. Compared with traditional preparations, the healing agent for anti-swelling and anti-infection of the present invention has a high effective rate of 88%, short healing period and no side effects in clinical use.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a healing agent for preventing swelling and resisting infection after a surgery. The healing agent comprises 0.05-0.1wt% of cetylpyridinium chloride, 1-2wt% of serrapeptase, 50-70wt% of an epidermal growth factor, 0.5-0.8wt% of xanthan gum, 5-10wt% of collagen, 0.2wt% of phenoxyethanol, 0.6-0.8wt% of ethylhexylglycerin and 16.1-42.65wt% of plasmin. The healing agent is directly placed into a wound or on the surface of the wound, and is high in drug concentration in a surgical area, significant in effect, high in patient acceptance and controllable in medical compliance; the healing agent can effectively prevent wound swelling, reduce pains and prevent infection, and has a significant wound healing accelerating effect; the healing agent is a pure natural biological preparation, is an anti-inflammatory drug not containing any antibiotic, does not contain hormones and sedatives, does not stimulate mucosae, and is free of side effects and adverse reactions.

Description

technical field [0001] The invention relates to a medicine for treating surgical infection, in particular to a healing agent for preventing swelling and anti-infection after surgery. Background technique [0002] Surgical infection is a clinical frequently-occurring disease, accounting for about 1 / 2-1 / 3 of the total number of surgical outpatients. Typical symptoms are redness, swelling, fever, pain, or dysfunction in the infected area. In severe cases, systemic poisoning reactions may occur, and even life threatening. At present, anti-infection and anti-swelling drugs, these drugs are basically oral products, containing antibiotics, hormones and sedative drugs, which produce dependence, have a certain impact on the central nervous system and the body's microcirculation, and have certain toxic and side effects , At the same time, there is no medicine that simultaneously solves the three problems. These medicines are not effective in solving the problems of easy swelling, inf...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/48A61P17/02A61P29/00A61P31/00A61K31/08A61K31/085A61K31/44A61K31/723A61K38/18A61K38/39
CPCA61K9/0014A61K31/08A61K31/085A61K31/44A61K31/723A61K38/1808A61K38/39A61K38/48A61K38/484C12Y304/21007A61K2300/00
Inventor 滕敏子
Owner 滕敏子
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap